MRK vs TMO
By Alex · Tickerpine
Merck & Co., Inc. vs Thermo Fisher Scientific Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | TMO |
|---|---|---|
| Price | $145.27 | $673.82 |
| Market cap | $358.41B | $249.14B |
| P/E ratio | 117.2 | 35.5 |
| ROE | 6.96% | 13.38% |
| Profit margin | 4.77% | 14.94% |
| Revenue growth | 5.10% | 9.10% |
| Dividend yield | 2.34% | 0.28% |
| Beta | 0.22 | 0.88 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs TMO in plain English
- MRK is the bigger company — about 1.4× the market cap of TMO.
- TMO is cheaper on earnings (P/E 35.5 vs 117.2).
- TMO earns a higher return on equity (13% vs 7%).
- TMO is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.34% vs 0.28%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.